Stallion India Fluorochemicals Q1 FY26 Concall Decoded: “Cool Gases, Hot Ambitions”
1. Opening Hook
While the world was busy sweating over US tariffs and a border flare-up with Pakistan, Stallion calmly puffed out 50% YoY revenue growth. That’s right—while air-conditioners guzzled refrigerants, Stallion minted profits. Management spent 90 minutes convincing analysts that their Bhilwara and Mambattu plants will be India’s answer to Honeywell. Spoiler: the call had more chemistry than a Karan Johar film, with phrases like “R-32 backward integration” and “helium specialty gases”. Buckle up—this isn’t just earnings, it’s a Bollywood-science crossover.
2. At a Glance
Revenue up 50.3% – Quarter hotter than Delhi in June.
EBITDA up 12.7% – Margins refused to party, stayed in 13% zone.
PAT up 21.5% – Healthy, but not gym-rat shredded.
Rajasthan R-32 Plant CapEx ~₹200 Cr – Because importing is sooo 2020.
PAT Margins future 17–18% – Once manufacturing kicks in, profits go keto.
Target turnover ₹2,500 Cr by FY30 – From small cylinders to mega-dreams.
3. Management’s Key Commentary
Quote: “We signed an MoU with Rajasthan for a ₹200+ Cr R-32 refrigerant gas plant.” (Translation: Why import coolant when we can mint it at home? Desi jugaad meets chemistry lab.)
Quote: “Most of our products are multi-use—fire safety, aerosols, blowing agents.” (Translation: Our gases are like Govinda—fit in every role, comedy to tragedy.)
Quote: “Backward integration into R-32 makes us future-proof.” (Translation: Nobody can ghost us on supply—our crush makes their own roses now.)
Quote: “PAT margins in manufacturing could hit 24%.” (Translation: For once, EBITDA may not ghost PAT like a toxic ex.)
Quote: “Our IPO delay let us re-engineer plants to 300-bar standard.” (Translation: Late to the party, but arrived in Gucci.)
Quote: “Target turnover ₹2,500 Cr by 2029.” (Translation: Think Marvel’s multiverse, but with cylinders and fluorine.)
